Passage Summary: A consumer advocate argues that because we don't understand the social effects of one new allergy medication, we should slow down the release of every new drug currently being tested.

Conclusion: The process of bringing all currently tested new drugs to the market should be slowed down.

Reasoning: We shouldn't sell drugs without knowing their social impact, and we currently don't understand the social impact of a specific new antihistamine.

Analysis: This argument takes a specific problem (one antihistamine) and uses it to justify a broad, industry-wide slowdown. To strengthen this, we need to show that the antihistamine isn't just a one-off fluke. If the lack of understanding regarding this antihistamine is representative of a broader trend among all drugs in testing, the conclusion becomes much more reasonable. Look for an answer that bridges the gap between this one unclear drug and the rest of the pipeline.